Information Provided By: 
Fly News Breaks for March 4, 2020
SYK
Mar 4, 2020 | 16:55 EDT
Citi analyst Joanne Wuensch initiated coverage of Stryker with a Buy rating and $235 price target. The analyst notes that the company has transformed itself through a series of acquisitions and has consistently delivered top tier revenue growth through its Orthopedics, MedSurg and Neurotech/Spine franchises. Wuensch adds that the company's current earnings multiple of 19-times is in line with its peer group, even though the stock has historically traded at a premium valuation given its premium high-single-digit revenue growth.
News For SYK From the Last 2 Days
There are no results for your query SYK
